BIO KEY INTERNATIONAL INC (BKYI) - Dilution Analysis

S-1 filing: This prospectus relates to the resale of common stock issuable upon exercise of warrants.

10-Q filing | 6.6M shares outstanding

10-Q filing | 5.8M shares outstanding

S-1 filing: This S-1 filing relates to the resale of up to 3,091,668 shares of common stock by a selling stockholder, which were originally issued in a private placement.

10-K filing | 3.7M shares outstanding

8-K filing: BIO-key International, Inc. entered into a warrant exercise agreement with an existing institutional investor to exercise warrants for 2,061,112 shares at $1.85 per share, resulting in gross proceeds of approximately $3.8 million, and also closed two exchange agreements to exchange Partitioned Notes for 489,635 shares of common stock. ($3.8M proceeds)

8-K filing: BIO-key International, Inc. acquired 5 million shares of Boumarang Inc. common stock from Fiber Food Systems, Inc. in exchange for 595,000 shares of BIO-key common stock, representing 19.0% of BIO-key's issued and outstanding shares prior to the transaction.

8-K filing: BIO-key International, Inc. closed a Securities Purchase Agreement with Fiber Food Systems, Inc. and Boumarang Inc., where the Company acquired 5 million shares of Boumarang common stock in exchange for 595,000 shares of BIO-key common stock, representing 19.0% of the Company's issued and outstanding shares prior to the closing. ($5.0M proceeds)

10-Q filing | 3.1M shares outstanding

S-1 filing: This prospectus relates to the resale of up to 2,061,112 shares of common stock issued and sold by the company in a private placement transaction.

8-K filing: BIO-key International, Inc. entered into a warrant exercise agreement with an existing accredited investor to exercise warrants for 1,030,556 shares of common stock at a reduced exercise price of $1.85 per share, resulting in gross proceeds of approximately $1.9 million for the Company. ($1.9M proceeds)

10-Q filing | 1.7M shares outstanding

10-Q filing | 1.8M shares outstanding

10-K filing | 1.0M shares outstanding

S-1 filing: This S-1 filing relates to the resale of up to 436,509 shares of common stock by the selling stockholder, which were originally issued in a private placement.

8-K filing | Stock split 1-for-18 | Outstanding: 941,000 → 52,277 | Transactions: Issuance 872502 Common stock $0.55M to Dillon Hill Investment Company LLC; Issuance 2270335 Warrant to Dillon Hill Investment Company LLC; Issuance 4714285 Warrant to Dillon Hill Investment Company LLC | Proceeds: $0.55M

8-K filing: Stock split 1-for-18 | Outstanding: 9,081,873 → 941,000

10-Q filing | 9.1M shares outstanding

8-K filing: BIO-key International, Inc. completed a public offering, issuing 4,230,000 shares of common stock, 17,200,000 pre-funded warrants, and 21,430,000 common warrants at a price of $0.175 per unit, resulting in net proceeds of approximately $3.3 million. ($3.75M proceeds)

S-1/A filing: This S-1/A filing details a proposed offering by BIO-key International, Inc. for up to 45,454,545 units, each consisting of either one share of common stock or one pre-funded warrant and one common warrant, underwritten by Maxim Group LLC.

S-1 filing: The company is offering units consisting of common stock and warrants, as well as pre-funded units, aiming to raise up to $10,000,000 through a best-efforts offering managed by Maxim Group LLC.

10-Q filing | 9.0M shares outstanding

8-K filing: BIO-key International, Inc. entered into a Waiver and Amendment No. 1 to Securities Purchase Agreement with AJB Capital Investments, LLC, amending the original agreement and addressing the issuance of a $2,200,000 principal amount senior secured promissory note and the issuance of 700,000 commitment shares. ($0.0M proceeds)

S-1 filing: This S-1 filing relates to the resale of up to 900,000 shares of common stock of BIO-key International, Inc. by a selling stockholder.

10-Q filing | 8.9M shares outstanding

10-K filing | 9.2M shares outstanding

8-K filing: BIO-key International, Inc. entered into a securities purchase agreement with AJB Capital Investments, LLC for a $2,200,000 principal amount senior secured promissory note, issuing 700,000 Commitment Shares and a warrant to purchase 200,000 Warrant Shares.

10-Q filing | 8.1M shares outstanding

10-Q filing | 8.1M shares outstanding

10-Q filing | 7.9M shares outstanding

10-K filing | 7.9M shares outstanding

10-Q filing | 7.8M shares outstanding

10-Q filing | 7.8M shares outstanding

S-3 filing: BIO-KEY INTERNATIONAL, INC. is offering up to $60,000,000 in total of any combination of common stock and preferred stock, either individually or in units, and common stock upon the exercise of warrants from time to time.

10-Q filing | 7.8M shares outstanding

POS AM filing: BIO-key International, Inc. is offering up to 3,979,775 shares of common stock underlying warrants previously issued.

10-K filing | 7.8M shares outstanding

10-Q filing | 62.4M shares outstanding

10-Q filing | 60.4M shares outstanding

8-K filing: BIO-key International, Inc. closed a public offering of 29,130,000 shares of common stock, pre-funded warrants to purchase 4,100,000 shares, and warrants to purchase 33,230,000 shares, with net proceeds of approximately $22.8 million, including the full exercise of the Over-Allotment option.

S-1/A filing: The company is offering 15,000,000 shares of common stock and warrants to purchase up to 15,000,000 shares of our common stock. Also offering pre-funded warrants to purchase 15,000,000 shares of our common stock.

S-1/A filing: The company is offering 18,750,000 shares of common stock and warrants to purchase up to 18,750,000 shares of common stock, as well as pre-funded warrants to purchase 18,750,000 shares of common stock for certain purchasers.

S-1 filing: This S-1 filing describes an offering of common stock, pre-funded warrants, and warrants to purchase common stock.

8-K filing: BIO-key International, Inc. closed a securities purchase agreement with Lind Global Macro Fund, LP for the issuance of a $1,811,250 principal amount senior secured convertible note, and issued a warrant to purchase 1,425,000 shares and 136,575 shares to the Investor for a due diligence fee. ($0.1M proceeds)

10-Q filing | 21.6M shares outstanding

10-K filing | 21.2M shares outstanding

8-K filing: BIO-key International, Inc. entered into a securities purchase agreement with Lind Global Macro Fund, LP, issuing a $2,415,000 senior secured convertible note, a warrant to purchase 1,900,000 shares of common stock, and 114,943 shares of common stock at $1.16 per share. ($0.13M proceeds)

8-K filing: BIO-key International, Inc. entered into a sales incentive agreement with Technology Transfer Institute, where TTI can earn shares of common stock and warrants based on revenue generated for the Company.